General Info

UCB Pharma is one of many wholly-owned subsidiaries of UCB S.A., a biopharmaceutical leader specializing in fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology. The company s main products include Keppra, Xyzal, Nootropil, Atarax, Lortab, Tussionex, Metadate CD, Equasym XL and Dipentum. The company directs profits from the sale and distribution of its products toward further research in its many fields. UCB Pharma s parent company maintains numerous additional facilities worldwide. The company recently acquired Celltech Group, helping form one of the world s largest biopharmaceutical companies. UCB was founded in 1928 by Emmanuel Janssen, a far-sighted Belgian businessman. UCB Pharma maintains its headquarters in Smyrna, Ga.